Chronic Kidney Disease Progression in Heart Failure: What We Know, Don't Know, and Where to Next?

Competing Interests: Funding Support and Author Disclosures Dr Heerspink has received grant support from the National Kidney Foundation (NKF) to his institute; and has served as a consultant for Alexion, Bayer, Boehringer Ingelheim, Chinook, CSL Behring, Dimerix, Eli Lilly, Gilead, Janssen, Merck, Novo Nordisk, and Travere Pharmaceuticals. Dr Neuen has received fees for advisory boards, scientific presentations, continuing education, steering committee roles, and travel from AstraZeneca, Bayer, Boehringer Ingelheim, Cambridge Healthcare, Cornerstone Medical Education, the Limbic, Medscape, and Travere Pharmaceuticals, with all honoraria paid to his institution. Dr Inker has received funding from the National Institutes of Health (NIH), NKF, Omeros, Chinook, and Reata Pharmaceuticals for research and contracts to Tufts Medical Center; has received consulting agreements with Tufts Medical Center with Tricida; and has received consulting agreements with Dimerix.